$DHTI

IMAGING TECHNOLOGIES CORP/CA

CIK:0000725394|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Mar. 31, 2026	Mar. 31, 2025
Total revenues	$ 2,567,104	$ 4,574,276	$ 9,925,823	$ 13,719,789
Cost of revenues	1,786,660	3,169,317	7,460,304	10,316,781
Gross profit	780,444	1,404,959	2,465,519	3,403,008
Operating expenses:
Selling, general and administrative	4,064,964	5,343,732	14,642,615	18,109,736
Total operating expenses	4,064,964	5,343,732	14,642,615	18,109,736
Loss from operations	(3,284,520)	(3,938,773)	(12,177,096)	(14,706,728)
Other income (expense):
Interest expense	(1,053,546)	(298,028)	(2,631,664)	(2,397,642)
Interest income	39	17,881	5,095	58,163
Other expense	(7,747)	(2,034)	(4,317)	(784,959)
Gain (loss) on foreign exchange	19,487	(1,575)	20,225	70,084
Total other expense, net	(1,041,767)	(283,756)	(2,610,661)	(3,054,354)
Loss before taxes	(4,326,287)	(4,222,529)	(14,787,757)	(17,761,082)
Provision for Income Taxes	0	0	26,180	7,524
Net loss	(4,326,287)	(4,222,529)	(14,813,937)	(17,768,606)
Other comprehensive loss
Foreign currency translation	102,480	(52,333)	262,466	(2,679)
Comprehensive loss	(4,223,807)	(4,274,862)	(14,551,471)	(17,771,285)
Net income (loss) attributable to noncontrolling interests	960	(27,030)	(9,682)	(52,507)
Net loss attributable to Dalrada Technology Group Inc. stockholders	$ (4,327,247)	$ (4,195,499)	$ (14,804,255)	$ (17,716,099)
Net loss per common share to Dalrada stockholders – basic	$ (0.04)	$ (0.05)	$ (0.14)	$ (0.19)
Net loss per common share to Dalrada stockholders – diluted	$ (0.04)	$ (0.05)	$ (0.14)	$ (0.19)
Weighted average common shares outstanding – basic	108,488,220	92,934,331	108,488,220	92,135,080
Weighted average common shares outstanding – diluted	108,488,220	92,934,331	108,488,220	92,135,080
Unrelated Parties [Member]
Total revenues	$ 1,942,865	$ 4,092,398	$ 8,720,236	$ 12,712,133
Related Parties [Member]
Total revenues	$ 624,239	$ 481,878	$ 1,205,587	$ 1,007,656

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (14,813,937)	$ (17,768,606)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	655,136	732,073
Stock compensation	410,224	1,647,067
Changes in operating assets and liabilities, net of amounts acquired or assumed in connection with acquisition:
Accounts receivable	(314,492)	471,132
Other receivables	17,109	482,624
Inventories	(30,811)	(206,806)
Prepaid expenses and other current assets	29,008	(99,406)
Noncurrent receivables	(549,379)	26,578
Accounts payable and accrued liabilities - related parties	6,989,461	9,440,875
Accounts payable and accrued liabilities	1,401,303	(1,449,145)
Decrease in Right of Use Asset/Liability	9,083	27,969
Contingent consideration	0	209,715
Deferred revenue	133,778	341,976
Net cash used in operating activities	(6,063,517)	(6,143,953)
Cash flows from investing activities:
Purchase of property and equipment	0	(287,080)
Purchase of intangibles	0	(146,449)
Acquisition of business, net of cash	0	(46,269)
Net cash used in investing activities	0	(479,798)
Cash flows from financing activities:
Net proceeds (repayments) from related party notes payable	4,626,639	3,903,354
Repayments of notes payable	0	0
Net proceeds (repayments) from notes payable	656,782	1,532,573
Additional Paid in Capital	12,277,907	672,554
Stock issued	(11,850,439)	114,863
Net cash provided by financing activities	5,710,889	6,223,344
Net change in cash and cash equivalents	(352,628)	(400,407)
Effect of exchange rate changes on cash	262,466	(2,679)
Cash and cash equivalents at beginning of period	502,094	501,927
Cash and cash equivalents at end of period	411,932	98,841
Supplemental disclosure of cash flow information:
Cash paid for income taxes	18,680	0
Cash paid for interest	1,277,813	2,099,614
Supplemental disclosure of non-cash investing and financing activities:
Conversion of related party notes and interest into preferred stock	0	17,243,235
Preferred stock issued pursuant to business combination	0	4,596,290
Warrants issued pursuant to acquisitions	17,245	11,496
(Decrease) Increase in right-of-use asset and liability	$ (4,848)	$ (27,969)

Consolidated Balance Sheets (unaudited) - USD ($)	Mar. 31, 2026	Jun. 30, 2025
Current assets:
Cash and cash equivalents	$ 82,625	$ 172,787
Restricted cash	329,307	329,307
Accounts receivable, net	2,386,017	2,747,194
Accounts receivable, net - related parties	1,769,289	1,093,620
Inventories	2,720,656	2,689,845
Prepaid expenses and other current assets	662,151	708,268
Total current assets	7,950,045	7,741,021
Long-term receivables	16,544	18,261
Long-term receivables - related parties	1,464,132	913,036
Property and equipment, net	900,963	1,273,315
Goodwill	1,526,042	1,531,893
Intangible assets, net	2,814,234	3,110,826
Right-of-use asset, net - Operating	2,324,783	2,629,794
Right-of-use asset, net - related party - Operating	721,292	1,140,749
Total assets	17,718,035	18,358,895
Current liabilities:
Accounts payable	4,429,922	4,175,896
Accrued liabilities	2,657,754	1,256,451
Accounts payable and accrued liabilities – related parties	10,523,659	3,387,977
Deferred revenue	1,640,464	1,506,686
Notes payable, current portion	9,143,168	3,937,797
Lease Liability, current portion - Operating	903,174	899,402
Lease Liability, current portion - related - Operating	605,567	578,631
Total current liabilities	29,903,708	15,742,840
Noncurrent payables
Notes payable, net of current portion	377,827	4,926,416
Notes payable, net of current portion – related parties	6,328,054	1,701,415
Contingent consideration	211,289	211,289
Lease Liability, net of current portion - Operation	1,563,870	1,850,671
Lease Liability, net of current portion - related party - Operating	155,389	614,681
Total liabilities	38,540,137	25,047,312
Commitments and contingencies (Note 12)
Stockholders’ equity (deficit):
Common stock, $0.005 par value, 500,000,000 shares authorized, 120,157,113 and 120,157,113 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively	600,785	600,785
Common stock to be issued	18,262	7,265
Preferred stock to be issued	0	11,861,578
Additional paid-in capital	188,527,695	176,249,788
Accumulated deficit	(210,137,584)	(195,323,647)
Accumulated other comprehensive loss	111,930	(150,536)
Total Dalrada Technology Group’s stockholders’ equity (deficit)	(20,877,912)	(6,753,909)
Noncontrolling interests	55,810	65,492
Total stockholders’ equity (deficit)	(20,822,102)	(6,688,417)
Total liabilities and stockholders’ equity	17,718,035	18,358,895
Series I Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock value	700	558
Series H Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock value	150	150
Series G Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock value	100	100
Series F Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock value	$ 50	$ 50